Rebecca Bowen, MD
Otolaryngology · Lincoln, NENPI 1548471865
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 125 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by Sanofi at 40.7% of the total.
Across 125 payments — averaging $18.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$935
- GSK$230
- Regeneron Healthcare Solutions, Inc.$206
- AbbVie$171
- Aerin Medical Inc.$146
- Optinose US, Inc.$137
- plus $473 from 12 others
What the payments were for
- Food & beverage$2,298100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 54 | $935 |
| GSK | 16 | $230 |
| Regeneron Healthcare Solutions, Inc. | 9 | $206 |
| AbbVie | 6 | $171 |
| Aerin Medical Inc. | 7 | $146 |
| Optinose US, Inc. | 8 | $137 |
| Stryker | 3 | $85 |
| Novartis | 4 | $73 |
| Organogenesis Inc. | 3 | $64 |
| Integra Lifesciences Corporation | 3 | $60 |
| Amgen | 2 | $36 |
| Smith+Nephew | 2 | $34 |
| Alk-abello, Inc | 2 | $29 |
| Merck | 2 | $24 |
| Pharming Healthcare, Inc. | 1 | $23 |
| Sanofi-aventis U.S. LLC | 1 | $16 |
| Acclarent, Inc | 1 | $15 |
| Inspire Medical Systems, Inc. | 1 | $15 |
How this compares
$2,298 in reported general payments places this provider in the 70th percentile of 86 otolaryngology providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 13 | $57,382 |
| Omeprazole | 84 | $1,380 |
| Fluticasone Propionate | 53 | $1,111 |
| Ofloxacin | 33 | $978 |
| Doxycycline Hyclate | 47 | $872 |
| Ipratropium Bromide | 18 | $619 |
| Cefdinir | 15 | $406 |
| Montelukast Sodium | 22 | $395 |
| Pilocarpine Hcl | 13 | $390 |
| Famotidine | 28 | $305 |
| Pantoprazole Sodium | 15 | $282 |
| Mupirocin | 23 | $280 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 15 | $252 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 14 | $172 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 16 | $147 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Lincoln
- Aaron RobinsonLincoln$51K
- Jenna BergLincoln$4K
- Sarah WhiteLincoln$3K
- Christopher CederbergLincoln$3K
- Jesse SchmidLincoln$3K
- Benton NelsonLincoln$3K
- Nichole HejtmanekLincoln$2K
- Dana WolfeLincoln$2K
- Kathryn RosenbergerLincoln$2K
- Howard SemmLincoln$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.